These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24705169)

  • 41. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma concentration of donepezil to the therapeutic response of Alzheimer's disease in Taiwanese.
    Yang YH; Wu SL; Chou MC; Lai CL; Chen SH; Liu CK
    J Alzheimers Dis; 2011; 23(3):391-7. PubMed ID: 21098979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
    López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J
    Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study.
    Arai H; Takahashi T
    Am J Geriatr Psychiatry; 2009 Apr; 17(4):353-4. PubMed ID: 19307864
    [No Abstract]   [Full Text] [Related]  

  • 47. Serum adipokine levels modified by donepezil treatment in Alzheimer's disease.
    Pákáski M; Fehér A; Juhász A; Drótos G; Fazekas OC; Kovács J; Janka Z; Kálmán J
    J Alzheimers Dis; 2014; 38(2):371-7. PubMed ID: 23979024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of the intrinsic clearance of donepezil (Aricept) between in vivo and in vitro studies in rat, dog and human.
    Matsui K; Taniguchi S; Yoshimura T
    Xenobiotica; 1999 Nov; 29(11):1059-72. PubMed ID: 10598742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPET.
    Ramakrishnan NK; Visser AK; Schepers M; Luurtsema G; Nyakas CJ; Elsinga PH; Ishiwata K; Dierckx RA; van Waarde A
    Psychopharmacology (Berl); 2014 Oct; 231(20):3997-4006. PubMed ID: 24639047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
    Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M
    Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies.
    Patel HP; Chaudhari PS; Gandhi PA; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA
    Int J Pharm; 2021 May; 600():120474. PubMed ID: 33737093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Donepezil dosing strategies: pharmacokinetic considerations.
    Gomolin IH; Smith C; Jeitner TM
    J Am Med Dir Assoc; 2011 Oct; 12(8):606-608. PubMed ID: 21943887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of a primary physicochemical determinant in the direct transport of drugs to the brain after nasal administration in rats: potential involvement of transporters in the pathway.
    Lee KR; Maeng HJ; Chae JB; Chong S; Kim DD; Shim CK; Chung SJ
    Drug Metab Pharmacokinet; 2010; 25(5):430-41. PubMed ID: 20924140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecularly imprinted microparticles in lipid-based formulations for sustained release of donepezil.
    Ruela AL; de Figueiredo EC; de Araújo MB; Carvalho FC; Pereira GR
    Eur J Pharm Sci; 2016 Oct; 93():114-22. PubMed ID: 27519666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel anionic polymer as a carrier for CNS delivery of anti-Alzheimer drug.
    Jakki SL; Ramesh YV; Gowthamarajan K; Senthil V; Jain K; Sood S; Pathak D
    Drug Deliv; 2016 Nov; 23(9):3471-3479. PubMed ID: 27246872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long Acting Ionically Paired Embonate Based Nanocrystals of Donepezil for the Treatment of Alzheimer's Disease: a Proof of Concept Study.
    Mittapelly N; Thalla M; Pandey G; Banala VT; Sharma S; Arya A; Mishra S; Mitra K; Shukla S; Mishra PR
    Pharm Res; 2017 Nov; 34(11):2322-2335. PubMed ID: 28808833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer's disease.
    Al Harthi S; Alavi SE; Radwan MA; El Khatib MM; AlSarra IA
    Sci Rep; 2019 Jul; 9(1):9563. PubMed ID: 31266990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Omega-3 Fatty Acids and Butter Oil in Targeting Delivery of Donepezil Hydrochloride Microemulsion to Brain via the Intranasal Route: a Comparative Study.
    Khunt D; Shrivas M; Polaka S; Gondaliya P; Misra M
    AAPS PharmSciTech; 2020 Jan; 21(2):45. PubMed ID: 31900652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.
    Hanafy AS; Farid RM; Helmy MW; ElGamal SS
    Drug Deliv; 2016 Oct; 23(8):3111-3122. PubMed ID: 26942549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic Study.
    Rajput A; Butani S
    AAPS PharmSciTech; 2022 Feb; 23(2):74. PubMed ID: 35149912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.